Grading crohn disease activity with MRI: Interobserver variability of MRI features, MRI scoring of severity, and correlation with crohn disease endoscopic index of severity

American Journal of Roentgenology

Volumn 201, Issue 6, 2013, Pages 1220-1228

  Tielbeek, Jeroen A W ^a   Makanyanga, Jesica C ^b   Bipat, Shandra ^a   Pendse, Doug A ^b   Nio, C Yung ^a   Vos, Frans M ^a,c   Taylor, Stuart A ^b   Stoker, Jaap ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Crohn disease; MR enterography; MRI; Observer variation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COLONOSCOPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ENDOSCOPIC INDEX OF SEVERITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; EDEMA; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM;

ADULT; AGED; COLONOSCOPY; CONTRAST MEDIA; CROHN DISEASE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84888365163     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.10341     Document Type: Article

References (33)

1. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: A prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989; 30:983-989.
2. Borley NR, Mortensen NJ, Jewell DP, Warren BF. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J Pathol 2000; 190:196-202.
3. VanAssche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003; 98:332-339.
4. Horsthuis K, Bipat S, Stokkers PCF, Stoker J. Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: A systematic review. Eur Radiol 2009; 19:1450-1460.
5. Pariente B, Peyrin-Biroulet L, Cohen L, Zagdanski A-M, Colombel J-F. Gastroenterology review and perspective: The role of cross-sectional imaging in evaluating bowel damage in Crohn disease. AJR 2011; 197:42-49.
6. Sinha R, Verma R, Verma S, Rajesh A. MR enterography of Crohn disease. Part 1. Rationale, technique, and pitfalls. AJR 2011; 197:76-79.
7. Sinha R, Verma R, Verma S, Rajesh A. MR enterography of Crohn disease. Part 2. Imaging and pathologic findings. AJR 2011; 197:80-85.
8. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location- matched histologic validation of MR imaging features. Radiology 2009; 252:712-720.
9. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006; 238:517-530.
10. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 2004; 14:1017-1024.
11. Zappa M, Stefanescu C, Cazals-Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011; 17:984-993.
12. Ziech MLW, Bipat S, Roelofs JJTH, et al. Retrospective comparison of magnetic resonance imaging features and histopathology in Crohn's disease patients. Eur J Radiol 2011; 80:e299-e305.
13. Rimola J, Ordás I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011; 17:1759-1768.
14. Masselli G, Gualdi G. MR imaging of the small bowel. Radiology 2012; 264:333-348.
15. Steward MJ, Punwani S, Proctor I, et al. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 2012; 81:2080-2088.
16. Ziech MLW, Lavini C, Caan MWA, et al. Dynamic contrast-enhanced MRI in patients with luminal Crohn's disease. Eur J Radiol 2012; 81:3019-3027.
17. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-444.
18. Ziech ML, Bossuyt PM, Laghi A, Lauenstein TC, Taylor SA, Stoker J. Grading luminal Crohn's disease: which MRI features are considered as important? Eur J Radiol 2012; 81:e467-e472.
19. Semelka RC, Shoenut JP, Silverman R, Kroeker MA, Yaffe CS, Micflikier AB. Bowel disease: prospective comparison of CT and 1.5-T pre- And postcontrast MR imaging with T1-weighted fatsuppressed and breath-hold FLASH sequences. J Magn Reson Imaging 1991; 1:625-632.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.
21. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4:7-27.
22. Negaard A, Sandvik L, Mulahasanovic A, Berstad AE, Klöw N-E. Magnetic resonance enteroclysis in the diagnosis of small-intestinal Crohn's disease: diagnostic accuracy and inter- And intra-observer agreement. Acta Radiol 2006; 47:1008-1016.
23. Jensen MD, Ormstrup T, Vagn-Hansen C, Østergaard L, Rafaelsen SR. Interobserver and intermodality agreement for detection of small bowel Crohn's disease with MR enterography and CT enterography. Inflamm Bowel Dis 2011; 17:1081-1088.
24. Sharman A, Zealley I, Greenhalgh R, Bassett P, Taylor S. MRI of small bowel Crohn's disease: determining the reproducibility of bowel wall gadolinium enhancement measurements. Eur Radiol 2009; 19:1960-1967.
25. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR 2009; 193:113-121.
26. Florie J, Horsthuis K, Hommes DW, et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin Gastroenterol Hepatol 2005; 3:1221-1228.
27. Oussalah A, Laurent V, Bruot O, et al. Diffusionweighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010; 59:1056-1065.
28. Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol 2007; 17:2294-2301.
29. Rimola J, Rodriguez S, García-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009; 58:1113-1120.
30. Froehlich JM, Waldherr C, Stoupis C, Erturk SM, Patak MA. MR motility imaging in Crohn's disease improves lesion detection compared with standard MR imaging. Eur Radiol 2010; 20:1945-1951.
31. Menys A, Atkinson D, Odille F, et al. Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn's disease activity: A preliminary study. Eur Radiol 2012; 22:2494-2501.
32. Girometti R, Zuiani C, Toso F, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum. Acad Radiol 2008; 15:153-164.
33. Fiorino G, Bonifacio C, Padrenostro M, et al. Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease. Dig Dis Sci 2013 Aug 1 [Epub ahead of print].